Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...

Merck (MRK) announced the first data presentation from the pivotal 3475A-D77 Phase 3 trial, evaluating the subcutaneous administration of ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Top health care investment bankers say that large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...

NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

Bangladesh reported a first outbreak of highly pathogenic bird flu on a farm since 2018, the World Organisation for Animal ...

Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...